News and Announcements
First Drop Wines ‘VIVO’ ARNEIS features in the Australian’s luxury lifestyle magazine WISH
- Published September 10, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
In an article posted by the Australian’s monthly luxury lifestyle magazine, WISH, First Drop Wine’s ‘VIVO’ ARNEIS has been identified as leading the way in diversifying Australian wine culture with an Italian influence.
The article reviews the wine as “made from a lesser-known Piedmontese grape variety, this wine shows fantastic varietal character – green apple, grapefruit and nashi pear fruits with a touch of floral complexity, it is lightweight but lacks for nothing, with a punchy, bright, crisp finish.”
About First Drop Wines
First Drop Wines is a multi-award winning Halliday rated – 5 red star winery.
Based in the heart of the Australian wine industry, this Barossa winery set to go to the next level, spearheaded by its iconic ‘Mother’s Milk’ Barossa Shiraz. The last five consecutive vintages of ‘Mother’s Milk’ Barossa Shiraz have been awarded 90+ points by Wine Spectator.
Working with 44 distribution partners across 20 countries, First Drop is poised to expand in growth markets, USA and China, whilst further opportunities lie in unlocking value in domestic multiples and cellar door sales.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
